Lineage Cell Therapeutics, Inc.
$1.11
+0.03 (+2.78%)
Price as of Sep 02, 2026 market close
Performance
- 1 Month
- -0.9%
- 3 Months
- -7.5%
- YTD
- -33.5%
- 1 Year
- -9.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 56.1%
- Largest decline max drawdown, since Aug 2025
- -47.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.11
Own LCTX?
See how LCTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.